Both IPF and experimental animal models of lung fibrosis are characterized by a redox imbalance and an increased production of reactive oxygen species (ROS), mainly derived from NADPH oxidase (NOX) 4 and mitochondria. Here, FMO5 is linked to pulmonary fibrosis.